Teva And Cephalon's Marketing Ignored Plea Deal, Judge Told

By Bonnie Eslinger · May 26, 2022, 11:31 PM EDT

Teva and Cephalon improperly peddled their painkiller Fentora even after Cephalon reached a 2008 plea agreement to resolve criminal claims it marketed a different opioid for unapproved uses, San Francisco's lawyer...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Case Title

City and County of San Francisco et al v. Purdue Pharma L.P. et al

Case Number

3:18-cv-07591

Court

California Northern

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

December 18, 2018

Recent Articles By Bonnie

November 25, 2024
BREAKING: Jury Finds Natera Owes Guardant $292.5M In False Ad Suit
November 22, 2024
Natera's Conduct 'Despicable,' Guardant Says As Trial Wraps
November 05, 2024
Eye-Rolling Must Stop, Judge Warns Before False Ad Trial
October 11, 2024
9th Circ. Backs Planned Parenthood's $14M Atty Fee Win
October 03, 2024
Texas Transgender Health Rule Suit Paused For Gov't Appeal
October 02, 2024
Lab Co. Settles Bogus Testing Claims With Feds For $27M
August 28, 2024
Del. Justices OK Mid-Case Appeal In Zantac Class Suit
August 16, 2024
States Get Teva Generic Price-Fix Case On Docket As 1st Trial
August 09, 2024
DC Circ. Pans Suit Claiming HHS Caused Health Aid Shortage
June 28, 2024
Texas Justices Back Ban On Gender Affirming Care For Minors

Teva And Cephalon's Marketing Ignored Plea Deal, Judge Told

Related Sections

Case Information

Case Title

Case Number

Court

Nature of Suit

Date Filed

Case Title

Case Number

Court

Nature of Suit

Date Filed

Recent Articles By Bonnie